RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.05
+0.41 (7.27%)
At close: Jul 28, 2026, 4:00 PM EDT
6.05
0.00 (0.07%)
After-hours: Jul 28, 2026, 7:34 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $250.45 million as of July 28, 2026. Its market cap has decreased by -22.67% in one year.
Market Cap
250.45M
Enterprise Value
43.40M
1-Year Change
-22.67%
Ranking
Category
Stock Price
$6.05
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $250.45M, a decrease of -40.98%. That is a compound annual growth rate of -10.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 250.45M | -41.54% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CapsoVision | 332.51M |
| Electromed | 331.12M |
| Perspective Therapeutics | 323.89M |
| Standard BioTools | 304.44M |
| 908 Devices | 290.06M |
| Sight Sciences | 288.92M |
| Profound Medical | 268.82M |
| Treace Medical Concepts | 267.28M |